Published in Medical Letter on the CDC and FDA, November 4th, 2007
"We commend Merck for the development of this new HIV/AIDS drug that shows...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.